27
Jan
2027
LTS Lohmann Device Technologies
Exhibitor at Pharmapack Europe 2027 stand 4H66, General Zone
About Us
Categories
-
Country/Region:Israel
-
On CPHI since:2024
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Event information
Pharmapack Europe 2027
-
27 Jan 2027 - 28 Jan 2027
-
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
-
Visit us at stand 4H66, General Zone
Products Featured at Pharmapack Europe 2027
-
Product MAP - Microneedle Array Patches
Microneedle Array Patches (MAP) are designed to enhance delivery through the intradermal route delivering a wide range of APIs including biologics and vaccines. MAP use tiny needles that penetrate the top layer of skin, dissolve and release their active ingredients. Our MAP platform is based on dissolvable... -
Product OBDS- On Body Delivery System
Designed with both patient and pharma in mind, the SorrelTM OBDS wearable platform is digitally integrated to deliver greater data for the pharma eco-system and enable better adherence for the patient. Based on our patents and ground-breaking design, Sorrel™is suited for multiple configurations, molecules,... -
Product OTF - Oral Thin Films
Oral Thin Films (OTF) are immediately absorbed, with the active substance quickly entering the bloodstream with no pain or complicated administration. Designed for delivery of fast acting therapies, our ready to use platform, coupled with your API, will encourage brand loyalty in patients and create tangib... -
Product TOPS - Topical Patch Systems
Topical Patch Systems (TOPS) is a flexible, ready to use platform designed to deliver a range of topical therapies, while avoiding first-pass metabolism and improving drug efficacy. Through synergies with transdermal experience, our innovative topical patch technology provides for product differentiation a... -
Product TTS - Transdermal Therapeutic Systems
Transdermal Therapeutic Systems (TTS) from is a proven, yet flexible, ready to use platform designed to deliver a range of active substances, e.g. small molecues. Our patches bypass the gastro- intestinal tract, avoiding the first-pass effect for maximum potency and effectiveness. With unmatched expertise ...

